Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, NeoCore Technology Co's enterprise value is NT$1,400.3 Mil.
NeoCore Technology Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$13.2 Mil. Therefore, NeoCore Technology Co's EV-to-EBITDA for today is 106.31.
The historical rank and industry rank for NeoCore Technology Co's EV-to-EBITDA or its related term are showing as below:
ROCO:4131'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -84.85 Med: -16.87 Max: 648.91
Current: 106.31
During the past 13 years, the highest EV-to-EBITDA of NeoCore Technology Co was 648.91. The lowest was -84.85. And the median was -16.87.
ROCO:4131's EV-to-EBITDA is ranked worse than 91.58% of 404
companies
in the Biotechnology industry
Industry Median: 13.02
vs ROCO:4131: 106.31
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
NeoCore Technology Co (ROCO:4131) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
NeoCore Technology Co's PE Ratio (TTM) for today is calculated as:
NeoCore Technology Co's share price for today is NT$31.90.
NeoCore Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-0.490.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
NeoCore Technology Co EV-to-EBITDA Historical Data
* Premium members only.
The historical data trend for NeoCore Technology Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4131 vs VRTX, REGN, MRNA: EV-to-EBITDA Comparison
For the Biotechnology subindustry, NeoCore Technology Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeoCore Technology Co EV-to-EBITDA vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NeoCore Technology Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where NeoCore Technology Co's EV-to-EBITDA falls into.
NeoCore Technology Co's current Enterprise Value is NT$1,400.3 Mil.
NeoCore Technology Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$13.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeoCore Technology Co (ROCO:4131) has a EV-to-EBITDA of 106.31 as of Sep. 14, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on NeoCore Technology Co. According to the industry distribution chart, NeoCore Technology Co ranks #370 out of 404 companies in the Biotechnology industry, placing it in the top 91.6%.
Is NeoCore Technology Co's EV-to-EBITDA too high?
NeoCore Technology Co's current EV-to-EBITDA is 106.31. The Biotechnology industry median EV-to-EBITDA is 13.02. NeoCore Technology Co's value of 106.31 is 716.5% above this industry median. Based on the distribution chart, NeoCore Technology Co ranks #370 out of 404 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, NeoCore Technology Co has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does NeoCore Technology Co's EV-to-EBITDA compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, NeoCore Technology Co ranks #370 out of 404 companies for EV-to-EBITDA. This places NeoCore Technology Co in the lower half of its industry. The industry median EV-to-EBITDA is 13.02. NeoCore Technology Co's value of 106.31 is 716.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Biotechnology company?
The median EV-to-EBITDA among Biotechnology companies is 13.02, based on 404 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NeoCore Technology Co's current EV-to-EBITDA of 106.31 is 716.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on NeoCore Technology Co. For the Biotechnology industry, the median EV-to-EBITDA is 13.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeoCore Technology Co's current EV-to-EBITDA is 106.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeoCore Technology Co stock overvalued right now?
Based on GuruFocus' analysis, NeoCore Technology Co (ROCO:4131) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$36.63, compared to a current price of NT$31.90 — trading 12.9% below its estimated fair value. The current EV-to-EBITDA is 106.31 and 716.5% above the Biotechnology industry median of 13.02. NeoCore Technology Co's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For NeoCore Technology Co (ROCO:4131), the current EV-to-EBITDA is 106.31 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NeoCore Technology Co (ROCO:4131) Overvalued in 2026?
Based on GuruFocus' analysis, NeoCore Technology Co stock appears to be undervalued.
The current stock price of NT$31.90 is trading 12.9% below its estimated GF Value™ of NT$36.63.
GuruFocus considers NeoCore Technology Co to be Modestly Undervalued.
Key valuation signals for ROCO:4131:
EV-to-EBITDA: 106.31
GF Value™: NT$36.63 vs. price of NT$31.90 (12.9% below fair value)
Industry Position: 716.5% above the Biotechnology median (#370 of 404)
No single metric tells the full story. See the ROCO:4131 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NeoCore Technology Co Ltd develops integrated bio-chip technology. Its products are used for food, beer, agriculture, livestock, and human disease testing.
55GF Score
Get the complete analysis for ROCO:4131
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4131 has been successfully added to your 
